SHSE •
Healthcare •
Biotechnology •
Quote as of 08/14/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeSHSE
Market Capitalization4,264.96 mln
Float22.03 mln
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.57
Likely reliable
Relative Strength
100
/ 100
Top performer
Debt / Equity
0.03
Debt-free
ROE
-3.71
Negative
Dividend Yield
0.00%
No dividend
Business Description
Founded in 2009 and based in Suzhou, China, Novoprotein Scientific Inc. supplies biological materials and technical services to drug makers, research labs, and diagnostic companies across Asia, Europe, the Americas, and Oceania. Its product range covers proteins, antibodies, enzymes, reagents, and materials used in mRNA-based medicines, gene and cell therapies, and disease testing. The company also takes on custom work such as protein production, antibody development, and RNA manufacturing for clients in life sciences and biopharma.
